IL40597A - Drug treatment of active antihypertensive agents containing active amino acid against high blood pressure and inhibitory B-hydroxylase - Google Patents

Drug treatment of active antihypertensive agents containing active amino acid against high blood pressure and inhibitory B-hydroxylase

Info

Publication number
IL40597A
IL40597A IL40597A IL4059772A IL40597A IL 40597 A IL40597 A IL 40597A IL 40597 A IL40597 A IL 40597A IL 4059772 A IL4059772 A IL 4059772A IL 40597 A IL40597 A IL 40597A
Authority
IL
Israel
Prior art keywords
methyl
amino
group
acceptable carrier
pharmaceutically acceptable
Prior art date
Application number
IL40597A
Other languages
English (en)
Hebrew (he)
Other versions
IL40597A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL40597A0 publication Critical patent/IL40597A0/xx
Publication of IL40597A publication Critical patent/IL40597A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL40597A 1971-11-11 1972-10-17 Drug treatment of active antihypertensive agents containing active amino acid against high blood pressure and inhibitory B-hydroxylase IL40597A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1637771 1971-11-11
CH1354572 1972-09-15

Publications (2)

Publication Number Publication Date
IL40597A0 IL40597A0 (en) 1972-12-29
IL40597A true IL40597A (en) 1976-06-30

Family

ID=25712489

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40597A IL40597A (en) 1971-11-11 1972-10-17 Drug treatment of active antihypertensive agents containing active amino acid against high blood pressure and inhibitory B-hydroxylase

Country Status (9)

Country Link
US (1) US3883656A (en。)
AU (1) AU4864272A (en。)
BE (1) BE791253A (en。)
DE (1) DE2254018A1 (en。)
FR (1) FR2159413B1 (en。)
GB (1) GB1405949A (en。)
IE (1) IE36780B1 (en。)
IL (1) IL40597A (en。)
NL (1) NL7214607A (en。)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389415A (en) * 1978-01-24 1983-06-21 Merck & Co., Inc. Method of treating hypertension
US4321264A (en) * 1980-04-14 1982-03-23 Merck & Co., Inc. α-methyldopa compositions
DE68929288T2 (de) * 1988-12-19 2001-11-15 Nec Corp., Tokio/Tokyo Datenübertragungsvorrichtung

Also Published As

Publication number Publication date
IE36780L (en) 1973-05-11
AU4864272A (en) 1974-05-09
IE36780B1 (en) 1977-02-16
FR2159413B1 (en。) 1975-08-08
NL7214607A (en。) 1973-05-15
BE791253A (fr) 1973-05-10
IL40597A0 (en) 1972-12-29
AU472689B2 (en。) 1976-06-03
FR2159413A1 (en。) 1973-06-22
DE2254018A1 (de) 1973-05-30
GB1405949A (en) 1975-09-10
US3883656A (en) 1975-05-13

Similar Documents

Publication Publication Date Title
ES8300112A1 (es) Un procedimiento para preparar compuestos de cefem .
RU95101430A (ru) Производные 1-бифенилметилимидазола, их получение, фармацевтическая композиция, способ лечения или профилактики гипертонии
GB1222708A (en) Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
IE41474L (en) Thiomethylergolines
GB1437136A (en) Anti-inflammatory thiazole compounds compositions and methods for using same
RU96101800A (ru) Производные амида фенилциклогексилкарбоновой кислоты, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция с антиартериосклеротической и антирестенозной активностью
IL40597A (en) Drug treatment of active antihypertensive agents containing active amino acid against high blood pressure and inhibitory B-hydroxylase
GB1277239A (en) Cycloalkane-carboxylic acid derivatives
ES8405005A1 (es) Un procedimiento para la preparacion de derivados del acido tetrahidrofurancarboxilico.
GB1289358A (en。)
GB1173227A (en) Amino-Isoquinolines
GB1097531A (en) Improvements in or relating to the preparation of cyclopentane derivatives
IE45178L (en) Phenothiazine derivatives
US4148879A (en) Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters
US4148878A (en) Inhibition of platelet aggregation with selected phosphoric acid esters
GB1291644A (en) Substituted 1-indancarboxylic acids, their esters and salts
GB1247711A (en) Antibacterial agents and a process for the preparation thereof
US4086354A (en) Novel anti-hypertensive compositions
JPH0365338B2 (en。)
GB1385831A (en) Acylamino-cephem-carboxylic acids and process for their preparation
GB1499420A (en) Ergot peptide alkaloids
US3898266A (en) Methylsulfonyl-benzoic acid derivatives
GB1377610A (en) 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof
KR850700244A (ko) 세팔로스포린 유도체 및 그 염의 제조방법
GB1470493A (en) Anti-hypertensive 4-1-2-naphthyl-methyl-1,2,5,6-tetrahydro pyrid-4-yl-chroman-5-ol esters